FindTrial
Sign In

Screening and follow-up study of congenital cytomegalovirus infection in Nantong

Screening and follow-up study of congenital cytomegalovirus infection in Nantong

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041019
Enrollment
Unknown
Registered
2020-12-16
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital cytomegalovirus infection

Interventions

Symptomatic newborns with hearing loss:Antiviral and symptomatic treatment
Symptomatic newborns without hearing loss:Antiviral and symptomatic treatment
Asymptomatic newborns with hearing loss:Antiviral and symptomatic treatment
Asymptomatic newborns without hearing loss:No treatment
No infection:Nil

Sponsors

Nantong Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Live birth; 2.Children aged <= 21 days; 3.The parents or legal guardians of the infants sign the informed consent.

Exclusion criteria

Exclusion criteria: The infant's health status is unstable.

Design outcomes

Primary

MeasureTime frame
Infection rate;Hearing loss;—

Secondary

MeasureTime frame
Number needed to treat;Late-onset hearing loss;—

Countries

China

Contacts

Public ContactGang Qin

Nantong Maternal and Child Health Hospital

tonygqin@ntu.edu.cn+86 18912288206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026